Fosun Pharma Trades Higher Following $950 Million Private Placement

Shanghai Fosun Pharma raised $940 million in a private placement with eight institutional investors. The company, which is a contender for first place in the "China's Biggest M&A Player" competition, has a large appetite for capital to fund its desire to make deals. After the announcement, Fosun gained 17% on the Hong Kong exchange and hit the 10% daily limit in Shanghai. More details.... Stock Symbol: (SHA: 600196; HK: 02196) Share this with colleagues: // //  
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.